imiquimod has been researched along with isotretinoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Jurado-Santa Cruz, F; Morales-Sánchez, MA; Olguin-García, MG; Peralta-Pedrero, ML | 1 |
| De la Torre Gomar, FJ; Gimeno Castillo, J; Saenz Aguirre, A | 1 |
1 trial(s) available for imiquimod and isotretinoin
| Article | Year |
|---|---|
A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Cryotherapy; Dermatologic Agents; Double-Blind Method; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Isotretinoin; Male; Treatment Outcome; Warts; Young Adult | 2015 |
2 other study(ies) available for imiquimod and isotretinoin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Extensive condyloma acuminata: Complete remission after oral isotretinoin and topical imiquimod. A successful combination?
Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Isotretinoin; Remission Induction | 2022 |